Original Source(s)
Related Content
FDA Okays Weekly Option in Achondroplasia
Navepegritide is described as the first therapy to deliver continuous C-type natriuretic peptide exposure over a weekly dosing interval in eligible pediatric patients.
March 2, 2026
-
2 min
Sleeve vs Gastric Bypass: Nutrient Intake at 1 Year
Investigators analyze 4-day food records and supplement reports from 285 patients at seven Swedish metabolic and bariatric centers in a substudy of the randomized BEST trial.
March 19, 2026
-
3 min
Ultrasound by Robot: The Debate
State proposes telerobotic scans to address rural gaps.
February 12, 2026
-
8 min